Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (32)

2024

  1. Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide

    Biomedicine and Pharmacotherapy, Vol. 170

2023

  1. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications

    Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257

  2. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs

    Biomedicine and Pharmacotherapy, Vol. 168

2019

  1. MEK5 promotes lung adenocarcinoma

    The European respiratory journal

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

2014

  1. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  2. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  3. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

2013

  1. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

    Epigenetics, Vol. 8, Núm. 6

2012

  1. Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer

    PLoS ONE, Vol. 7, Núm. 11

  2. New models towards assessing anti-cancer therapeutics

    Histology and Histopathology, Vol. 27, Núm. 2, pp. 157-170

  3. Prognostic impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas

    PLoS ONE, Vol. 7, Núm. 8

  4. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays

    Modern Pathology, Vol. 25, Núm. 4, pp. 590-601

2010

  1. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis

    Journal of Pathology, Vol. 221, Núm. 3, pp. 308-319

  2. Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157

2009

  1. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as potential therapeutic target

    PLoS ONE, Vol. 4, Núm. 5

2007

  1. Efecto de la hipotermia combinada con magnesio y tirilazad en un modelo experimental de isquemia cerebral difusa

    Medicina Intensiva, Vol. 31, Núm. 3, pp. 113-119

2006

  1. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 11, Núm. 2, pp. 1

  2. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 11, Núm. 2, pp. 69-74